drugset / Trial / NCT06299813

Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection

NCT06299813

Phase 3 Unknown 80 enrolled A.O.U. Città della Salute e della Scienza
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this double-blind, Placebo-controlled Randomized Study is to assess if a single dose of betamethasone in children with febrile adenoviral infection works well in achieving an early fever regulation. The experimentation is conducted to answer this question: "Can betamethasone help reduce fever more quickly in a child with viral adenovirus infection? "The secondary objective is to assess if the child's overall clinical conditions improve more rapidly (reduced sore throat, quicker return to regular eating) and a reduction in the incidence and duration of hospitalizations.

Timeline

Start
2024-03-20
Primary completion
2025-01-15
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 0.1 mg/kg
Subject Betamethasone Other / unclassified 0.5 mg
Subject Betamethasone Other / unclassified 1 mg
Subject Betamethasone Other / unclassified 1.5 mg
Subject Betamethasone Other / unclassified 2 mg
Subject Betamethasone Other / unclassified 2.5 mg